High-Flow Nasal Cannula versus Continuous Positive Airway Pressure in Critical Bronchiolitis: A Randomized Controlled Pilot.
Journal of pediatric intensive care · 2020-04-17 · Randomised trial
Abstract
We conducted a randomized controlled pilot study in infants with critical bronchiolitis ( n = 63) comparing high-flow nasal cannula (HFNC, n = 35) to continuous positive airway pressure (CPAP, n = 28). The primary outcome was treatment failure, defined as the need for bilevel positive pressure ventilation or endotracheal intubation. Treatment failure occurred in 10 patients (35.7%) in the CPAP group and 13 patients (37.1%) in the HFNC group ( p = 0.88). Pediatric intensive care unit length of stay was similar between the CPAP and HFNC groups (5 [4-7] days and 5 [4-8] days, p = 0.46, respectively). In this pilot study, treatment with HFNC resulted in a rate of treatment failure similar to CPAP.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Children · CPAP & NIV · High-flow nasal oxygen
Related articles
- Comparison of the efficacy of high-flow nasal cannula and bi-level positive airway pressure in children with asthma exacerbation: a systematic review and meta-analysis. (J Asthma, 2026)
- AARC and PALISI Clinical Practice Guideline: Pediatric Critical Asthma. (Respir Care, 2025)
- High-Flow Oxygen and Other Noninvasive Respiratory Support Therapies in Bronchiolitis: Systematic Review and Network Meta-Analyses. (Pediatr Crit Care Med, 2023)
- Clinical Interventions During Inter-hospital Transfer of Infants With Moderate-to-Severe Bronchiolitis: Implications for Advanced Nursing Practice. (Nurs Crit Care, 2026)
- High-Flow Nasal Cannula Versus Nasal Prong Bubble Continuous Positive Airway Pressure in Children With Moderate to Severe Acute Bronchiolitis: A Randomized Controlled Trial. (Pediatr Crit Care Med, 2024)
- Comparison of the effects of high-flow nasal cannula and bilevel positive airway pressure treatments as respiratory physiotherapy interventions for children with asthma exacerbation: a randomized clinical trial. (Einstein (Sao Paulo), 2024)